» Articles » PMID: 29605218

Six-minute Walk Test As a Determinant of the Functional Capacity of Children and Adolescents with Cystic Fibrosis: A Systematic Review

Overview
Journal Respir Med
Publisher Elsevier
Specialty Pulmonary Medicine
Date 2018 Apr 2
PMID 29605218
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Cystic Fibrosis (CF) is a multisystem disorder. The involvement of the respiratory system is frequent and culminates in dyspnea and exercise intolerance. Functional capacity is an important diagnostic tool, because it reflects the cardiorespiratory status, quality of life and prognosis. This systematic review aims to assess the reproducibility and validity of the six minute walk test (6MWT) to reflect the functional capacity of children and adolescents with cystic fibrosis, and also the correlation between 6MWT and lung function. Searches for articles were performed in eight databases using MeSH/DeCS keywords. A total of 695 articles were found and, after verifying all eligibility criteria, six articles were included for analysis and scoring regarding the methodological quality according to the QUADAS scale (Quality Assessment of Diagnostic Accuracy Studies). All articles had good methodology (QUADAS between 9 and 11 points). The 6MWT is not correlated with lung function. There is a strong indication that the 6MWT is a reproducible test to assess the functional capacity of children and adolescents with CF. The validity assessment could not be reached because the studies included in this systematic review did not use adequate statistical tools to carry out such an evaluation.

Citing Articles

Monitoring Activity and Gait in Children (MAGIC) using digital health technologies.

Di J, Tuttle P, Adamowicz L, Lin W, Zhang H, Psaltos D Pediatr Res. 2024; 96(3):750-758.

PMID: 38514860 PMC: 11499282. DOI: 10.1038/s41390-024-03147-x.


Guidance and standard operating procedures for functional exercise testing in cystic fibrosis.

Saynor Z, Gruet M, McNarry M, Button B, Morrison L, Wagner M Eur Respir Rev. 2023; 32(169).

PMID: 37558263 PMC: 10410399. DOI: 10.1183/16000617.0029-2023.


The PAY test: a new approach for assessing functional performance in children and adolescents with asthma.

Lanza F, Santos J, Selman J, Crispim A, Nascimento K, Souza G J Pediatr (Rio J). 2023; 99(6):597-603.

PMID: 37230151 PMC: 10594023. DOI: 10.1016/j.jped.2023.05.002.


"Just Move It . . . Move It": A Multidisciplinary Motivational Approach to Improve Physical Activity in Children With Cystic Fibrosis.

Sputael V, Gaspar V, Weber V, Soussi K, Knoop C, Hanssens L Glob Pediatr Health. 2023; 10:2333794X221150728.

PMID: 36911754 PMC: 9996715. DOI: 10.1177/2333794X221150728.


Effects of Elexacaftor/Tezacaftor/Ivacaftor on Cardiorespiratory Polygraphy Parameters and Respiratory Muscle Strength in Cystic Fibrosis Patients with Severe Lung Disease.

Giallongo A, Parisi G, Papale M, Manti S, Mule E, Aloisio D Genes (Basel). 2023; 14(2).

PMID: 36833376 PMC: 9956139. DOI: 10.3390/genes14020449.